MRSA Infections Pharmaceutical, Drug and Healthcare Pipeline Review H2
Jan 30, 2017
WiseGuyReports.com adds “Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Global Clinical Trials Review, H2, 2016” reports to its database.
Pune, India - January 30, 2017 /MarketersMedia/ —
Summary
“Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Global Clinical Trials Review, H2, 2016" provides an overview of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/910200-methicillin-resistant-staphylococcus-aureus-review-h2-2016
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Table of Content: Key Points
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Therapeutics Clinical Trials 29
Prominent Drugs 31
…Continued
ACCESS REPORT @ https://www.wiseguyreports.com/reports/910200-methicillin-resistant-staphylococcus-aureus-review-h2-2016
Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts
Contact Info:
Name: Norah Trent
Organization: WiseGuy Reports
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028 Maharashtra, India
Phone: +1-646-845-9349
Source URL: http://marketersmedia.com/mrsa-infections-pharmaceutical-drug-and-healthcare-pipeline-review-h2/165423
For more information, please visit http://www.wiseguyreports.com
Source: MarketersMedia
Release ID: 165423
More News
Angara welcomes DBM nod to 3,627 new DepEd Sulu positions
MANILA, Philippines — Education Secretary Sonny Angara welcomed on Monday the Department of Budget and Management’s approval of the creation of 3,627 teaching and teaching-related positions for the newly established Schools Division Office (SDO) of Sulu. — a major development for public school teachers and personnel across Sulu, “We know that there’s some worry about
Caap suspends flights at Iloilo airport to give way to emergency drills
MANILA, Philippines — Flight operations at the Iloilo International Airport in Cabatuan town, Iloilo province were temporarily suspended on Wednesday, Oct. 28. The suspension comes as the Civil Aviation Authority of the Philippines (Caap) is set to conduct emergency drills. In an advisory, the Caap said that the Notice to Airmen will take effect from
Estrada’s camp refutes Bonoan’s P7-B insertion claim anew
MANILA, Philippines — Sen. Jinggoy Estrada’s legal team on Tuesday reiterated that the lawmaker did not have insertions in the 2025 national budget. Earlier in the day, former Public Works and Highways secretary Manuel Bonoan told the Sandiganbayan Fifth Division in a written testimony that Estrada had over P7 billion in “congressional initiatives.” “Senator Estrada
Bomb threat triggers class suspension at Koronadal university
KORONADAL CITY — Classes were suspended Tuesday afternoon at Notre Dame of Marbel University (NDMU) here due to a bomb threat that prompted police to cordon off and inspect the campus. Lt. Col. Harold Cornel, Koronadal City police chief, said two pieces of vellum paper bearing threatening messages about alleged improvised explosive devices (IEDs) were
INQToday: Peso closes beyond 64
MANILA, Philippines — Here are our top stories for today, Tuesday, Oct. 27, 2026, as of 6 p.m. Peso closes beyond 64 The Philippine peso weakened past 64 per dollar for the first time on Tuesday, hitting another record low as economic uncertainty and external pressures weighed on the local unit. Palace to Bato dela
Cebu eases anti-ASF controls for lechon production
CEBU CITY — The Cebu provincial government has allowed the shipment of live hogs intended for lechon production, subject to protocols and biosecurity requirements. Gov. Pamela Baricuatro issued Executive Order (EO) No. 55 on Oct. 26, allowing the entry of pigs intended for lechon production. The policy allows lechon producers to source live hogs from
Barbers: Prenup or not, evidence vs Sara Duterte enough to convict her
MANILA, Philippines — Whether or not there is a prenuptial agreement between Vice President Sara Duterte and her husband Manases Carpio, the evidence presented during her impeachment trial is enough to merit a conviction. This statement came from impeachment prosecution panel spokesperson Robert Ace Barbers on Tuesday in a press briefing briefing at the Batasang Pambansa.
SC: Retirement before 65 requires voluntary employee consent
MANILA, Philippines — The Supreme Court (SC) has ruled that employees cannot be forced to retire before the compulsory retirement age of 65 without them giving clear and voluntary consent to their respective companies. In a decision promulgated on June 29, the SC’s First Division partly granted the petition of Rodolfo Ondevilla against Colegio de
Chief justice contender Zalameda defends gov’t officials on budget hike
MANILA, Philippines—Supreme Court Associate Justice Rodil Zalameda, a contender for the chief justice post, said public officials responsible for increasing unprogrammed appropriations under the national budget should be presumed to have acted in good faith. During his interview Monday before the Judicial and Bar Council (JBC), Zalameda said unprogrammed appropriations are constitutional and that official
Dole orders safety measures for riders amid extreme heat
MANILA, Philippines — The Department of Labor and Employment (Dole) on Tuesday issued guidelines requiring delivery platforms to implement safety measures as heat levels rise, including limiting or suspending deliveries under dangerous conditions. Labor Advisory No. 20, Series of 2026, signed by Labor Secretary Francis Tolentino on Oct. 27, sets safety protocols for employers and
Engineer: Martin Romualdez not among kickback recipients
MANILA, Philippines — A public works engineer who admitted to collecting and counting alleged kickbacks from Bulacan flood control projects said on Tuesday that former House Speaker Martin Romualdez was not among the recipients. Engineer John Carlo Rivera, who worked under former Department of Public Works and Highways (DPWH) District Engineer Henry Alcantara, testified to this
Cooler days seen as Pagasa declares onset of ‘amihan’ season
MANILA, Philippines — The state weather bureau on Tuesday officially declared the onset of the northeast monsoon or “amihan” season, which is expected to cause cooler weather, episodes of cold surges, and rough sea conditions. The Philippine Atmospheric, Geophysical and Astronomical Services Administration (Pagasa) said that the “amihan” will become the dominant weather system affecting
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.